Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kleanthis Gabriel Xanthopoulos currently holds 82,816 shares of Connect Biopharma Holdings Ltd (CNTB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kleanthis Gabriel Xanthopoulos has been a net neutral trader of CNTB stock. They have purchased $0 and sold $0 worth of shares.
Kleanthis Gabriel Xanthopoulos's most recent insider trade was on Mar 31, 2026, when they sold 2,816 shares at $0.00 per share.
Kleanthis Gabriel Xanthopoulos serves as Executive at Connect Biopharma Holdings Ltd (CNTB). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Kleanthis Gabriel Xanthopoulos holds the position of Executive at Connect Biopharma Holdings Ltd, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Kleanthis Gabriel Xanthopoulos has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Kleanthis Gabriel Xanthopoulos was on Mar 31, 2026, when they purchased $0 worth of CNTB shares. This transaction involved 2,816 shares at N/A per share.
Kleanthis Gabriel Xanthopoulos currently owns 82,816 shares of Connect Biopharma Holdings Ltd (CNTB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kleanthis Gabriel Xanthopoulos's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kleanthis Gabriel Xanthopoulos has 1 Form 4 filings on record as an insider at Connect Biopharma Holdings Ltd.
Set alerts for Kleanthis Gabriel Xanthopoulos and 40,000+ other insiders.